Erratum: Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Authors:

Published: 2024-04-30

DOI: 10.1200/jco.24.00821

Source: Full article

---

Abstract

No abstract found.